MetaCap

ANI Pharmaceuticals (ANIP) vs Kailera Therapeutics (KLRA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

ANI Pharmaceuticals is the larger company by market cap ($1.56 billion vs $1.43 billion), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ANIP-15.29%KLRA-57.62%
+10%-28%-65%
Apr 17, 20261 yearNov 20, 2026
ANIP-15.29%KLRA-57.62%
+10%-27%-63%
Apr 13, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ANIP versus KLRA key metrics
MetricANIPKLRA
Share price$68.55$11.02
Market cap$1.56B$1.43B
1-day change-0.84%-4.84%
YTD return-13.16%—
1-year return-14.01%—
5-year return+68.14%—
P/E ratio (TTM)13.90—
Forward P/E6.72—
EPS (TTM)$4.93$-4.16
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$883.37M—
Revenue growth (YoY)+43.78%—
Net income (latest FY)$78.34M—
Gross margin61.36%—
Operating margin12.58%—
Net margin8.87%—
52-week high$87.76$28.23
52-week low$67.14$9.76
Distance from 52-week high-21.89%-60.96%
Analyst consensusbuystrong_buy
Avg. price target upside+50.81%+290.20%
Average volume420.66K1.08M
Shares outstanding22.72M129.85M
Employees970145
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About ANI Pharmaceuticals

ANIP stock →

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products.

Health Care · Biotechnology: Pharmaceutical Preparations · 970 employees

About Kailera Therapeutics

KLRA stock →

Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions.

Health Care · Biotechnology: Pharmaceutical Preparations · 145 employees

ANIP vs KLRA FAQ

Which is bigger, ANI Pharmaceuticals or Kailera Therapeutics?

ANI Pharmaceuticals (ANIP) is larger, with a market capitalization of $1.56B compared with $1.43B for Kailera Therapeutics (KLRA).

Are ANI Pharmaceuticals and Kailera Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons